Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
24234 | 267 | 26.4 | 62% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
679 | 12474 | HYDRAZONOYL HALIDES//CYANOTHIOACETAMIDE//AZA WITTIG REACTION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DRUG RADIAT | Address | 63 | 62% | 24% | 65 |
2 | M PRC | Address | 27 | 62% | 10% | 28 |
3 | RADIOPROTECTIVE AGENTS | Author keyword | 3 | 43% | 2% | 6 |
4 | CIL 102 | Author keyword | 3 | 60% | 1% | 3 |
5 | SULFONAMIDE MOIETY | Author keyword | 2 | 67% | 1% | 2 |
6 | PYRIMIDOQUINOLINE | Author keyword | 1 | 38% | 1% | 3 |
7 | 4 ANILINO 2 PHENYLQUINOLINE DERIVATIVES | Author keyword | 1 | 100% | 1% | 2 |
8 | 6 ARYLINDENO1 2 CQUINOLINE DERIVATIVES | Author keyword | 1 | 100% | 1% | 2 |
9 | ANTIMICROBIAL AND ANTITUMOR AGENTS | Author keyword | 1 | 100% | 1% | 2 |
10 | ANTITUMOR AND RADIOPROTECTIVE ACTIVITIES | Author keyword | 1 | 100% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SULFONAMIDE MOIETY | 15 | 73% | 4% | 11 |
2 | RADIOPROTECTIVE AGENTS | 12 | 56% | 6% | 15 |
3 | ANTIPROLIFERATIVE EVALUATION | 6 | 45% | 4% | 10 |
4 | ACTIVE SULFONAMIDE MOIETY | 4 | 75% | 1% | 3 |
5 | SULFONE BISCOMPOUNDS | 3 | 100% | 1% | 3 |
6 | TAS 103 | 3 | 35% | 3% | 7 |
7 | POTENTIAL ANTITUMOR | 2 | 23% | 3% | 9 |
8 | 4 AMINO | 2 | 67% | 1% | 2 |
9 | ANTIRADIATION COMPOUNDS | 2 | 67% | 1% | 2 |
10 | TOPOISOMERASES I | 2 | 50% | 1% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
A review on anticancer potential of bioactive heterocycle quinoline | 2015 | 2 | 249 | 11% |
A Review on the Synthesis and Anti-cancer Activity of 2-substituted Quinolines | 2015 | 0 | 46 | 22% |
Anticancer Drug Design Using Scaffolds of beta-Lactams, Sulfonamides, Quinoline, Quinoxaline and Natural Products. Drugs Advances in Clinical Trials | 2012 | 13 | 107 | 6% |
Synthesis, structure, and physicochemical characteristics of thiols | 2005 | 12 | 69 | 9% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DRUG RADIAT | 63 | 62% | 24% | 65 |
2 | M PRC | 27 | 62% | 10% | 28 |
3 | BIOL RADIAT | 1 | 100% | 0.7% | 2 |
4 | RADIAT TECHNOL NCRRT | 1 | 40% | 0.7% | 2 |
5 | CELL BIOL ANAT PATHOL | 1 | 33% | 0.7% | 2 |
6 | GLOBAL PHARMACEUT EDUC | 1 | 50% | 0.4% | 1 |
7 | KAYYALI CHAIR | 1 | 50% | 0.4% | 1 |
8 | MED AROMAT POISONOUS PLANTS M PRC | 1 | 50% | 0.4% | 1 |
9 | VET ANIM OURCES | 1 | 50% | 0.4% | 1 |
10 | MED AROMAT POISONOUS PLANTS | 1 | 12% | 1.9% | 5 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000134477 | SULOFENUR//LY295501//ARYLSULFONYLIMIDAZOLIDINONE |
2 | 0.0000114365 | DEDC//HETEROCYCL UNIT//5 CHLOROANISIC ACID |
3 | 0.0000101070 | AZA WITTIG REACTION//GEWALD REACTION//IMINOPHOSPHORANE |
4 | 0.0000080688 | QUINOLINES//O AMINOARYL KETONES//FRIEDLANDER ANNULATION |
5 | 0.0000075016 | 4 FLUOROPYRIMIDINES//BE CYCLES//ELE OCHEM ENERGET |
6 | 0.0000072342 | CHEM TECHNOL DRUGS//2 MERCAPTOBENZENESULFONAMIDE//2 MERCAPTOBENZENESULFONAMIDES |
7 | 0.0000071859 | ORGAN MED CHEM//2 CHLORO 3 FORMYL QUINOLINES//THIOPYRANO2 3 BQUINOLINES |
8 | 0.0000071556 | PHYSYNOR//2 AMINOCHALCONES//PROD NAT ORIGINE VEGETALE SYNTH ORGAN |
9 | 0.0000069087 | BIOELECTROSTATICS//PORPHYRIN SCHIFF BASE//REGULATORY ACTION |
10 | 0.0000068603 | CHIM BIOINORGAN//CARBONIC ANHYDRASE//SEZ SCI FARMACEUT |